2fuc
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:2fuc.gif|left|200px]] | [[Image:2fuc.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_2fuc", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | | | + | --> |
| - | | | + | {{STRUCTURE_2fuc| PDB=2fuc | SCENE= }} |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''Human alpha-Phosphomannomutase 1 with Mg2+ cofactor bound''' | '''Human alpha-Phosphomannomutase 1 with Mg2+ cofactor bound''' | ||
| Line 31: | Line 28: | ||
[[Category: Silvaggi, N R.]] | [[Category: Silvaggi, N R.]] | ||
[[Category: Zhang, C.]] | [[Category: Zhang, C.]] | ||
| - | [[Category: | + | [[Category: Carbohydrate-deficient glycoprotein syndrome]] |
| - | [[Category: | + | [[Category: Haloalkanoic acid dehalogenase superfamily]] |
| - | [[Category: | + | [[Category: Phosphomannomutase]] |
| - | [[Category: | + | [[Category: Protein glycosylation]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:19:06 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 01:19, 4 May 2008
Human alpha-Phosphomannomutase 1 with Mg2+ cofactor bound
Overview
Congenital disorder of glycosylation type 1a (CDG-1a) is a congenital disease characterized by severe defects in nervous system development. It is caused by mutations in alpha-phosphomannomutase (of which there are two isozymes, alpha-PMM1 and alpha-PPM2). Here we report the x-ray crystal structures of human alpha-PMM1 in the open conformation, with and without the bound substrate, alpha-D-mannose 1-phosphate. Alpha-PMM1, like most haloalkanoic acid dehalogenase superfamily (HADSF) members, consists of two domains, the cap and core, which open to bind substrate and then close to provide a solvent-exclusive environment for catalysis. The substrate phosphate group is observed at a positively charged site of the cap domain, rather than at the core domain phosphoryl-transfer site defined by the Asp(19) nucleophile and Mg(2+) cofactor. This suggests that substrate binds first to the cap and then is swept into the active site upon cap closure. The orientation of the acid/base residue Asp(21) suggests that alpha-phosphomannomutase (alpha-PMM) uses a different method of protecting the aspartylphosphate from hydrolysis than the HADSF member beta-phosphoglucomutase. It is hypothesized that the electrostatic repulsion of positive charges at the interface of the cap and core domains stabilizes alpha-PMM1 in the open conformation and that the negatively charged substrate binds to the cap, thereby facilitating its closure over the core domain. The two isozymes, alpha-PMM1 and alpha-PMM2, are shown to have a conserved active-site structure and to display similar kinetic properties. Analysis of the known mutation sites in the context of the structures reveals the genotype-phenotype relationship underlying CDG-1a.
About this Structure
2FUC is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a., Silvaggi NR, Zhang C, Lu Z, Dai J, Dunaway-Mariano D, Allen KN, J Biol Chem. 2006 May 26;281(21):14918-26. Epub 2006 Mar 15. PMID:16540464 Page seeded by OCA on Sun May 4 04:19:06 2008
